Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
12 p, 653.9 KB HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy / Blanch Lombarte, Oscar (Institut Germans Trias i Pujol) ; Santos, José Ramón (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Peña, Ruth (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Jiménez Moyano, Esther (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Clotet, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Prado, Julia G (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Virological failure (VF) to boosted PIs with a high genetic barrier is not usually linked to the development of resistance-associated mutations in the protease gene. From a cohort of 520 HIV-infected subjects treated with lopinavir/ritonavir or darunavir/ritonavir monotherapy, we retrospectively identified nine patients with VF. [...]
2020 - 10.1093/jac/dkaa228
Journal of Antimicrobial Chemotherapy, Vol. 75 (june 2020) , p. 2535-2546  
2.
13 p, 347.6 KB Prediction of week 4 virological response in hepatitis C for making decision on triple therapy : the Optim study / Romero-Gómez, Manuel (Hospital de Valme (Sevilla)) ; Turnes, Juan (Complejo Hospitalario de Pontevedra) ; Ampuero, Javier (Hospital de Valme (Sevilla)) ; Oyagüez, Itziar (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Cuenca, Beatriz (Hospital Universitario Infanta Cristina (Madrid)) ; Gonzalez-García, Juan (Hospital Universitario La Paz (Madrid)) ; Muñoz-Molina, Belén (Roche Farma) ; Aguilar, Rocío (Fisevi (Sevilla)) ; Leal, Sandra (Fisevi (Sevilla)) ; Planas Vilà, Ramon (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia-Samaniego, Javier (Hospital Carlos III (Madrid)) ; Diago, Moisés (Consorci Hospital General Universitari (Valencia)) ; Crespo, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Calleja, Jose Luís (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Casado, Miguel Ángel (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Solà Lamoglia, Ricard (Hospital del Mar (Barcelona, Catalunya))
Background: Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1log10 IU/ml HCVRNA (D1L) should have treatment discontinued due to low SVR rate. [...]
2015 - 10.1371/journal.pone.0122613
PloS one, Vol. 10, No 3 (March 2015) , p. e0122613  
3.
7 p, 502.3 KB Classification models for neurocognitive impairment in HIV Infection based on demographic and clinical variables / Muñoz-Moreno, Jose Antonio (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Pérez-Álvarez, Núria (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Muñoz-Murillo, Amalia (Universitat de Barcelona) ; Prats, Anna (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Garolera i Freixa, Maite (Consorci Sanitari Hospital de Terrassa) ; Jurado, Ma. Ángeles (María Ángeles) (Universitat de Barcelona) ; Fumaz, Carmina R. (Rodríguez Fumaz) (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Negredo Puigmal, Eugènia (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Ferrer, Maria J. (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Clotet, Bonaventura (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Universitat Autònoma de Barcelona
Objective: We used demographic and clinical data to design practical classification models for prediction of neurocognitive impairment (NCI) in people with HIV infection. Methods: The study population comprised 331 HIV-infected patients with available demographic, clinical, and neurocognitive data collected using a comprehensive battery of neuropsychological tests. [...]
2014 - 10.1371/journal.pone.0107625
PloS one, Vol. 9 Issue 9 (September 2014) , p. e107625  
4.
8 p, 147.3 KB HIV-1 Viral loas assays for resource-limited settings / Fiscus, Susan A. (University of North Carolina at Chapel Hill (Estats Units d'Amèrica)) ; Cheng, Ben (Forum for Collaborative HIV Research (Washington, Estats Units d'Amèrica)) ; Crowe, Suzanne M. (Macfarlane Burnet Institute for Medical Research and Public Health (Melbourne, Austràlia)) ; Demeter, Lisa (University of Rochester School of Medicine and Dentistry (Rochester, Estats Units d'Amèrica)) ; Jennings, Cheryl (Rush University Medical Center (Chicago, Estats Units d'Amèrica)) ; Miller, Veronica (Forum for Collaborative HIV Research (Washington, Estats Units d'Amèrica)) ; Respess, Richard (Centers for Disease Control and Prevention (Atlanta, Estats Units d'Amèrica)) ; Stevens, Wendy (University of the Witwatersrand (Johannesburg, Sud-àfrica)) ; Martínez Picado, Francisco Javier (Universitat Autònoma de Barcelona.) ; Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group
Tremendous strides have been made in treating HIV-1 infection in industrialized countries. Combination therapy with antiretroviral (ARV) drugs suppresses virus replication, delays disease progression, and reduces mortality. [...]
2006 - 10.1371/journal.pmed.0030417
PLoS medicine, Vol. 3, Issue 10 (October 2006) , p.e417  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.